Loading Events

« All Events

Hybrid Event
  • This event has passed.

Characterizing Immune-12, a complex marine-derived nutraceutical that exhibits anti-cancer activity in vitro and in vivo with minimal toxicity

September 8, 2025 @ 11:30 am - 12:30 pm
Hybrid Event

Presented by:

Andrew Satterlee, Ph.D.
Screening Live Cancer Explants Program, Eshelman Innovation
UNC Eshelman School of Pharmacy
Division of Pharmacoengineering and Molecular Pharmaceutics

Register Here

Name(Required)
If attending via Zoom: https://zoom.us/j/98559693243


Hosted by: UNC Metabolomics and Proteomics (MAP) Core

Sponsored by: UNC Lineberger Comprehensive Cancer Center (LCCC)


Details